HIV-1 Tat protein and cell proliferation and survival: A brief review

New Microbiologica

Volumn 28, Issue 2, 2005, Pages 95-109

  Gibellini, Davide ^a   Vitone, Francesca ^a   Schiavone, Pasqua ^a   Re, Maria Carla ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Cell proliferation; HIV; Tat

Indexed keywords

TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

AUTOCRINE EFFECT; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PROTEIN SECRETION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAT; HIV-1; HUMANS; MICE; MICE, TRANSGENIC; PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21244494003     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (167)

1. ALBINI, A., SOLDI, R., GIUNCIUGLIO, D., GIRAUDO, E., BENELLI, R., PRIMO, L., NOONAN, D., SALIO, M., CAMUSSI, G., ROCKL, W. AND BUSSOLINO, F. (1996). The angiogenesis induced by HIV-1 Tat is mediated by the FIk-1/KDR receptor on vascular endothelial cells. Nat. Med. 2, 1371-1375.
2. ALBINI, A., FERRINI, S., BENELLI, R., SFORZINI, S., GIUNCIUGLIO, D., ALUIGI, M.G., PROUDFOOT, A.E., ALOUANI, S., WELLS, T.N., MARIANI, G., RABIN, R.L., FARBER, J.M. AND NOONAN, D.M. (1998). HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA, 95, 13153-13158.
3. BADOU, A., BENNASSER Y., MOREAU M., LECLERC C., BENKIRANE M., AND BAHRAOUI E. (2000). Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol, 74, 10551-10562.
4. BAGASRA, O., LAVI, E., BOBROSKI, L., KHALILI, K., PESTANER, J. P., TAWADROS, R., AND POMERANTZ, R. (1996). Cellular reservoirs of HIV-1 in the central nervous system of HIV-1-infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS, 10, 573-581.
5. BARBORIC, M., PETERLIN, B.M. (2005). A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation. PLoS Biol, 3, e76.
6. BARILLARI, G., GENDELMAN, R., GALLO, R.C., AND ENSOLI, B. (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA, 90, 7941-7945.
7. BARILLARI, G., C. SGADARI, C. PALLADINO, R. GENDELMAN, A. CAPUTO, C. B. MORRIS, B. C. NAIR, P. MARKHAM, A. NEL, M. STÜRZL, AND B. ENSOLI. (1999). Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the ?v?3 integrin. J. Immunol, 163, 1929-1935.
8. BARILLARI, G., AND ENSOLI, E. (2002). Angiogenic effects of extracellular Human Immunodeficiency Virus Type 1 Tat protein and its role in the pathogenesis of AIDS-Associated Kaposi's Sarcoma. Clin. Microbiol. Rev, 15, 310-326.
9. BENELLI, R., BARBERO, A., FERRINI, S., SCAPINI, P., CASSATELLA, M., BUSSOLINO, F., TACCHETTI, C., NOONAN, D.M., AND ALBINI, A. (2000). Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis. J. Infect. Dis, 182, 1643-1651.
10. BERGONZIN, V., DEL BUE, S., WANG, J.Y., REISS, K., PRISCO, M., AMINI, S., KHALILI, K., AND PERUZZI, F. (2004). HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation. Oncogene, 23, 7701-7711.
11. BISWAS, D.K., SALAS, T.R., WANG, F., AHLERS, C.M., DEZUBE, B.J., AND PARDEE, A.B. (1995). A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol, 69, 7437-7444.
12. BORGATTI, P., ZAULI, G., COLAMUSSI, M.L., GIBELLINI, D., PREVIATI, M., CANTLEY, L.L, AND CAPITANI, S. (1997). Extracellular HIV-1 Tat protein activates phosphatidylinositol-3 and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur. J. Immunol, 27, 2805-2811.
13. BRAKE, D., DEBOUCK, C., AND BIESECKER, G. (1990). Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J. Cell. Biol, 111, 1275-1281.
14. BROWN, J.A., HOWCROFT, T.K., AND SINGER, D.S. (1998). HIV Tat protein requirements for transactivation and repression of transcription are separable. J Acquir. Immune Defic. Syndr. Hum. Retrovirol, 17, 9-16.
15. BUONAGURO, L., BARILLARI, G., CHANG, H.K., BOHAN, C.A., KAO, V., MORGAN, R., GALLO, R.C., ENSOLI, B. (1992). Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol, 66, 7159-7167.
16. BUONAGURO, L., BUONAGURO, F.M., GIRALDO, G., ENSOLI, B. (1994). The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol, 68, 2677-2682.
17. CAFARO, A., CAPUTO, A., FRACASSO, C., MAGGIORELLA, M. T., GOLETTI, D., BARONCELLI, S., PACE, M., SERNICOLA, L., KOANGA-MOGTOMO, M. L., BETTI, M., BORSETTI, A., BELLI, R., AKERBLOM, L., CORRIAS, F., BUTTO, S., HEENEY, J., VERANI, P., TITTI, F., AND ENSOLI, B. (1999). Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med, 5, 643-650.
18. CANTALUPPI, V., BIANCONE, L., BOCCELLINO, M., DOUBLIER, S., BENELLI, R., CARLONE, S., ALBINI, A., CAMUSSI, G. (2001). HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. AIDS Res Hum Retroviruses, 17, 965-976.
19. CAPUTO, A., SODROSKI, J.G., AND HASELTINE, W.A. (1990). Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. J. Acquir Immune Defic Syndr. Hum. Retrovirol, 3, 372-379.
20. CHAO, C. C., HU, S., TSANG, M., WEATHERBEE, J., MOLITOR, T. W., ANDERSON, W. R., AND PETERSON, P. K. (1992). Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J. Clin. Invest, 90, 1786-1793.
21. CHEN, D, WANG, M., ZHOU, S., AND ZHOU, Q. (2002). HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the proapoptotic Bcl-2 relative Bim. EMBO J, 21, 6801-6810.
22. CHIRMULE, N., THAN, S., KHAN, S.A. AND PAHWA, S. (1995). Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol, 69, 492-498.
23. CHOWDHURY, M., TAYLOR, J.P., CHANG, C.F., RAPPAPORT, J., AND KHALILI, K. (1992). Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol, 66, 7355-7361.
24. CLARK, E., SANTIAGO, F., DENG, L., CHONG, S., DE LA FUENTE, C., WANG, L., FU, P., STEIN, D., DENNY, T., LANKA, V., MOZAFARI, F., OKAMOTO, T., KASHANCHI, F. (2000). Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1. J Virol. 74, 5040-5052.
25. CONANT, K., MA, M., NATH, A., MAJOR, E.O. (1996). Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J. Virol. 70, 1384-1389.
26. CONTI, L., RAINALDI, G., MATARRESE, P., VARANO, B., RIVABENE, R., COLOMBA, S., SATO, A., BELARDELLI, F., MALORI, W., AND GESSANI, S. (1998). The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J. Exp. Med, 187, 403-413.
27. CONTI, L., MATARRESE, P., VARANO, B., GAUZZI, M.C., SATO, A., MALORNI, W., BELARDELLI, F., AND SANDRA GESSANI, S. (2000). Dual Role of the HIV-1 Vpr Protein in the Modulation of the Apoptotic Response of T Cells. J. Immunol, 165, 3293-3300.
28. CONTRERAS, X., BENNASSER, Y., AND BAHRAOUI, E. (2004). IL-10 production induced by HIV-1 Tat stimulation of human monocytes is dependent on the activation of PKC beta(II) and delta isozymes. Microbes Infect, 6, 1182-1190.
29. CORALLINI, A., ALTAVILLA, G., POZZI, L., BIGNOZZI, F., NEGRINI, M., RIMESSI, P., GUALANDI, F., BARBANTI-BRODANO, G. (1993). Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res, 53, 5569-5575.
30. CORALLINI, A., CAMPIONI, D., ROSSI, C., ALBINI, A., POSSATI, L., RUSNATI, M., GAZZANELLI, G., BENELLI, R., MASIELLO, L., SPARACCIARI, V., PRESTA, M., MANNELLO, F., FONTANINI, G. AND BARBANTI-BRODANO, G. (1996). Promotion of tumor metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice. AIDS, 10, 701-710.
31. CORALLINI, A., SAMPAOLESI, R., POSSATI, L., MERLIN, M., BAGNARELLI, P., PIOLA, C., FABRIS, M., MENEGATTI, M.A., TALEVI, S., GIBELLINI, D., ROCCHETTI, R., CAPUTO, A., BARBANTI-BRODANO, G. (2002). Inhibition of HIV-1 Tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity. Virology, 299, 1-7.
32. CUPP, C., TAYLOR, J.P., KHALILI, K., AND AMINI, S. (1993). Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene. 8, 2231-2236.
33. DANG, C.V. AND LEE, W.M. (1989). Nuclear and nucleolar targeting sequences of c-erb-A, c-myc, N-myc, p53, HSP70 and HIV tat proteins. J Biol. Chem, 264, 18019-18023.
34. DAYTON, A.I., SODROSKI, J.G., ROSEN, C.A., GOH, W.C., AND HASELTINE, W.A. (1986). The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell, 44, 941-947.
35. DE LA FUENTE, C., SANTIAGO, F., DENG, L., EADIE, C., ZILBERMAN, I., KEHN, K., MADDUKURI, A., BAYLOR, S., WU, K., LEE, C.G., PUMFERY, A., KASHANCHI, F. (2002). Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem, 3, 14-27.
36. DE MAREUIL, J., CARRE, M., BARBIER, P., CAMPBELL, G.R., LANCELOT, S., OPI, S., ESQUIEU, D., WATKINS, J.D., PREVOT, C., BRAGUER, D., PEYROT, V., AND LORET, E.P. (2005). HIV-1 Tat protein enhances Microtubule polymerization. Retrovirology, 3, 5-11.
37. DE PAULIS, A., DE PALMA, R., DI GIOIA, L., CARFORA, M., PREVETE, N., TOSI, G., ACCOLLA, R.S. AND MARONE, G. (2000). Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J. Immunol, 165, 7171-7179.
38. DE FALCO, G., BELLAN, C., LAZZI, S., CLAUDIO, P., LA SALA, D., CINTI, C., TOSI, P., GIORDANO, A., AND LEONCINI, L. (2003). Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene, 22, 6214-6219.
39. DEMARCHI, F., D'ADDA DI FAGAGNA, F., FALASCHI, A., AND GIACCA, M. (1996). Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol, 70, 4427-4437.
40. DHAWAN, S., PURI, R.K., KUMAR, A., DUPLAN, H., MASSON, J.M., AND AGGARWAL, B.B. (1997). Human immunodeficiency virus-1-Tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood, 90, 1535-1544.
41. DINGWALL, C., ERNBERG, I., GAIT, M.J., GREEN, S.M., HEAPHY, S., KARN, J., LOWE, A.D., SINGH, M., SKINNER, M.A., AND VALERIO R. (1989). Human immunodeficiency virus 1 tat protein binds transactivation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA, 86, 6925-6929.
42. DINGWALL, C., ERNBERG, I., GAIT, M.J., GREEN, S.M., HEAPHY, S., KARN, J., LOWE, A.D., SINGH, M., AND SKINNER M.A. (1990). HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J, 9, 4145-4153.
43. EHRET, A., LI-WEBER, M., FRANK, R., AND KRAMMER, P.H. (2001). The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by Tat. Eur. J. Immunol, 31, 1790-1799.
44. ENSOLI, B., BARILLARI, G., SALAHUDDIN, S.Z., GALLO, R.C., AND WONG-STAAL, F. (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature, 345, 84-86.
45. ENSOLI, B., BUONAGURO, L., BARILLARI, G., FIORELLI, V., GENDELMAN, R., MORGAN, R.A., WINGFIELD, P., AND GALLO R.C. (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol, 67, 277-287.
46. ENSOLI, B., GENDELMAN R., MARKHAM P., FIORELLI V., COLOMBINI S., RAFFELD, M., CAFARO, A., CHANG, H.K., BRADY J.N., AND GALLO, R.C. (1994). Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature, 371, 674-680.
47. FINE, S. M., ANGEL, R. A., PERRY, S. W., EPSTEIN, L. G., ROTHSTEIN, J. D., DEWHURST, S., AND GELBARD, H. A. (1996). Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem, 271, 15303-15306.
48. FIORELLI, V., GENDELMAN, R., SAMANIEGO, F., MARKHAM, P., AND ENSOLI, B. (1995). Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest, 95, 1723-1734.
49. FIORELLI, V., BARILLARI, G., TOSCHI, E., SGADARI, C., MONINI, P., STURZL, M., AND ENSOLI. B. (1999). IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol, 162, 1165-1171.
50. FLORES, S.C., MARECKI, J.C., HARPER, K.P., BOSE, S.K., NELSON, S.K., AND MCCORD, J.M. (1993). Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA, 90, 7632-7636.
51. FORTIN, J.F., BARAT, C., BEAUSEJOUR, Y., BARBEAU, B. AND TREMBLAY, M.J. (2004). Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction. J. Biol. Chem, 279, 39520-39531.
52. FRANKEL, A.D. AND PABO, C.O. (1988). Cellular uptake of the Tat protein from human immunodeficiency virus. Cell, 55, 1189-1193.
53. FRANKEL, A.D. AND YOUNG, J.A. (1998). HIV-1 Fifteen proteins and an RNA. Ann. Rev. Biochem, 67, 1-25.
54. GALLO, RC. (1999). Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine. Proc. Natl. Acad. Sci. USA, 96, 8324-8326.
55. GANJU, R. K., MUNSHI, N., NAIR, B.C., LIU, Z.Y., GILL, P., AND GROOPMAN, J.E. (1998). Human immunodeficiency virus Tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinase and components of focal adhesion in Kaposi's sarcoma cells. J. Virol, 72, 6131-6137.
56. GIBELLINI, D., ZAULI, G., RE, M.C., MILANI, D., FURLINI, G., CARAMELLI, E., CAPITANI, S., AND LA PLACA, M. (1994). Recombinant human immunodeficiency virus type 1 (HIV-1) Tat protein sequentially upregulates IL-6 and TGFβ1 mRNA expression and protein synthesis in peripheral blood monocytes. British J. Haematol, 88, 261-267.
57. GIBELLINI, D., CAPUTO, A., CELEGHINI, C., BASSINI, A., LA PLACA, M., CAPITANI, S., AND ZAULI, G. (1995). Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. British J. Haematol, 89, 24-33.
58. GIBELLINI, D., CAPUTO, A., CAPITANI, S., LA PLACA, M., AND ZAULI, G. (1997). Upregulation of c-fos in activated T lymphoid and monocytic cells by Human Immunodeficiency Virus 1 Tat protein. Blood, 89, 1654-1664.
59. 133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. J. Immunol, 160, 3891-3898.
60. GIBELLINI, D., RE, M.C., PONTI, C., CELEGHINI, C., MELLONI, E., LA PLACA, M., AND ZAULI, G. (2001a). Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. British J. Haematol, 112, 663-670.
61. GIBELLINI, D., RE, M.C., PONTI, C., MALDINI, C., CELEGHINI, C., CAPPELLINI, A, LA PLACA, M., AND ZAULI, G. (2001b). HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis inducing ligand. Cell. Immunol, 207, 89-99.
62. GIBELLINI, D., RE, M.C., LA PLACA, M., AND ZAULI, G. (2002). Differentially expressed genes in HIV-1 tat-expressing T CD4+ T-cell line. Virus Res, 90, 337-345.
63. GIBELLINI, D., RE, M.C., VITONE, F., RIZZO, N., MALDINI, C., LA PLACA, M., AND ZAULI, G. (2003). Selective upregulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein. Clin. Exp. Immunol, 131, 428-435.
64. GIBELLINI, D., RE, M.C., PONTI, C., VITONE, F., BON, I., FABBRI, G., DI IASIO, M.G., AND ZAULI, G. (2004). HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity. J. Cell. Physiol, Epub ahead of print.
65. GOLDSTEIN, G. (1996). HIV-1 Tat protein as a potential AIDS vaccine. Nat. Med, 1, 960-964.
66. GONZALEZ, E., PUNZON, C., GONZALEZ, M., AND FRESNO, M. (2001). HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. J. Immunol, 166, 4560-4569.
67. GRINGERI, A., SANTAGOSTINO, Z., MUCA-PERJA, M., MANNUCCI, P. M., ZAGURY, J. F., BIZZINI, B., LACHGAR, A., CARCAGNO, M., RAPPAPORT, J., CRISCUOLO, M., BLATTNER, W., GALLO, R. C., AND ZAGURY, D. (1998). Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J. Hum. Virol, 1, 293-298.
68. GU, Y., WU, R.F., XU, Y.C., FLORES, S.C., AND TERADA, L.S. (2001). HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism. Virology, 286, 62-71.
69. GUO, H.G., PATI, S., SADOWSKA, M., CHARURAT, M., AND REITZ, M. (2004). Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J. Virol, 78, 9336-9342.
70. HAKANSSON, S., M. AND CAFFREY M. (2003). Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin bound states. Biochemistry, 42, 8999-9006.
71. HERBEUVAL, J.P., BOASSO, A., GRIVEL, J.C., HARDY, A.W., ANDERSON, S.A., DOLAN, M.J., CHOUGNET, C., LIFSON, J.D., AND SHEARER, G.M. (2005). TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood, 105, 2458-2464.
72. HO, W.Z., AYAVOO, V., SRINIVASAN, A., STINSKI, M.F., PLOTKIN, S.A., AND GONCZOL, E. (1991). Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication. AIDS Res Hum Retroviruses, 7, 689-695.
73. HOWCROFT, T.K., STREBEL, K., MARTIN, M.A., AND SINGER, D.S. (1993). Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science, 260, 1320-1322.
74. HUANG, L., BOSCH, I., HOFMANN, W., SODROSKI, J., AND PARDEE, A.B. (1998). Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J. Virol, 72, 8952-8960.
75. HUIGEN, M.C., KAMP, W., AND NOTTET H.S. (2004). Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur. J. Clin. Invest, 34, 57-66.
76. ITO, M., ISHIDA, T., HE, L., TANABE, F., RONGGE, Y., MIYAKAWA, Y., AND TERUNUMA, H. (1998). HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses, 14, 845-849.
77. JEANG, K.T., XIAO, H., RICH, E.A. (1999). Multifaceted activities of the HIV-1 transactivator of transcription Tat. J Biol. Chem, 274, 28837-28840.
78. JIA, H., LOHR, M., JEZEQUEL, S., DAVIS, D., SHAIKH, S., SELWOOD, D., AND ZACHARY, I. (2001). Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun, 283, 469-479.
79. KAO, S.Y., CALMAN, A.F., LUCIW, P.A., AND PETERLIN B.M. (1987). Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature, 330, 489-493.
80. KASHANCHI, F., PIRAS, G., RADONOVICH, M.F., DUVALL, J.F., FATTAEY, A., CHIANG, C.M., ROEDER, R.G., AND BRADY, J.N. (1994). Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature, 367, 295-299.
81. KIM, C.M., VOGEL, J., JAY, G., AND RHIM, J.S. (1992). The HIV tat gene transforms human keratinocytes. Oncogene, 7, 1525-1529.
82. KOENIG, S., GENDELMAN, H.E., ORENSTEIN, J., DALCANTO, M. C., PEZESHIKPOUR, G.H.J., YUNGBLUTH, I.M., JANNOTTA, F., AKSAMIT, A., MARTIN, M.A., AND FAUCI, A.S. (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science, 233, 1089-1093.
83. KOKEN, S.E., GREIJER, A.E., VERHOEF, K., VAN WAMEL, J., BURKRINSKAYA, A.G., AND BERKOUT, B. (1992). Intracellular analysis of in vitro modified HIV Tat protein. J Biol. Chem, 269, 8366-8374.
84. KOLSON, D. L., BUCHHALTER, J., COLLMAN, R., HELLMIG, B., FARRELL, C. F., DEBOUCK, C., AND GONZALES-SCARANO, F. (1993). HIV-1 tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res. Hum. Retroviruses, 9, 677-685.
85. KUMAR, A., DHAWAN, S., MUKHOPADHYAY, A., AND AGGARWAL, B.B. (1999). Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett, 462, 140-144.
86. KUNDU, R.K., SANGIORGI, F., WU, L.Y., PATTENGALE, P.K., HINTON, D.R., GILL, P.S., AND MAXSON, R. (1999). Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood, 94, 275-282.
87. KUPPUSWAMY, M., SUBRAMANIAN, T., SRINASAN, A., AND CHINNADURAI, G. (1989). Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Research 17, 3551-3561.
88. LASPIA, M.F., RICE, A.P., AND MATHEWS M.B. (1989). HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell, 59, 283-292.
89. LEVINE, M. AND MANLEY, J.L. (1989).Transcriptional repression of eukaryotic promoters. Cell, 59, 405-408.
90. LI, C.J., WANG, C., FRIEDMAN, D.J., AND PARDEE, A.B. (1995a). Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA, 92, 5461-5464.
91. LI, C.J., FRIEDMAN, D.J., WANG, C., METELEV, V., AND PARDEE, A.B. (1995b). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Sciente, 268, 429-431.
92. LI, C., UEDA, Y., SHI, B., BORODYANSKY, L., HUANG, L., LI, Y.Z. AND PARDEE, A.B. (1997). Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc. Natl. Acad. Sci. USA, 94, 8116-8120.
93. MA, M. AND NATH, A. (1997). Molecular determinants for cellular uptake of tat protein of human immunodeficiency virus type 1 in brain cells. J Virol, 71, 2495-2499.
94. MAGNUSON, D.S., KNUDSEN, B.E., GEIGER, J.D., BROWNSTONE, R.M., AND NATH, A. (1995). Human immunodeficiency virus type 1 tat activates non-N-methyl-?-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol, 37, 373-380.
95. MAHIEUX, R., LAMBERT, P.F., AGBOTTAH, E., HALANSKI, M.A., DENG, L., KASHANCHI, F., AND BRADY J.N. (2001). Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein. J Virol, 75, 1736-1743.
96. MARCELLO, A., LUSIC, M., PEGORARO, G., PELLEGRINI, V., BELTRAM, F., AND GIACCA, M. (2004). Nuclear organization and the control of HIV-1 transcription. Gene 326, 1-11.
97. MARECKI, J.C., COTA-GOMEZ, A., VAITAITIS, G.M., HONDA, J.R., PORNTADAVITY, S., ST CLAIR, D.K., AND FLORES, S.C. (2004). HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity. Free Radic Biol Med, 37, 869-880.
98. DEREGIBUS, M.C., CANTALUPPI, V., DOUBLIER, S., BRIZZI, M.F., DEAMBROSIS, I., ALBINI, A., AND CAMUSSI, G. (2002). HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem, 277, 25195-25202.
99. MCCLOSKEY, T.W., OTT, M., TRIBBLE, E., KHAN, S.A., TEICHBERG, S., PAUL, M.O., PAHWA, S., VERDIN, E., AND CHIRMULE, N. (1997). Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol, 158, 1014-1019.
100. MILANI, D., MAZZONI, M., BORGATTI, P., ZAULI, G., CANTLEY, L., AND CAPITANI, S. (1996). Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J Biol Chem, 271, 22961-22964.
101. fak and its association with phosphoinositide 3-kinase in PC12 cells. AIDS 12, 1275-1284.
102. MISCHIATI, C., PIRONI, F., MILANI, D., GIACCA, M., MIRANDOLA, P., CAPITANI, S., AND ZAULI, G. (1999). Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. AIDS, 13, 1637-1645.
103. MITOLA, S., SOZZANI, S., LUINI, W., PRIMO, L., BOSATTI, A., WEICH, H., BUSSOLINO, F. (1997). Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelialgrowth factor receptor-1. Blood, 90, 1365-1372.
104. MITOLA, S., SOLDI, R., ZANON, I., BARRA, L., GUTIERREZ, M.I., BERKHOUT, B., GIACCA, M. AND BUSSOLINO, F. (2000). Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J. Virol, 74, 344-353.
105. MIURA, Y., MISAWA, N., KAWANO, Y., OKADA, H., INAGAKI, Y., YAMAMOTO, N., ITO, M., YAGITA, H., OKUMURA, K., MIZUSAWA, H., KOYANAGI, Y. (2003). Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci USA, 100, 2777-2782.
106. MOSES, A. V., SIENGLEIN, S. G., STRUSSENBERG, S.J., WEHRLY, G K., CHESEBRO, B., AND NELSON, J.A. (1996). Sequences regulating tropism of human immunodeficiency virus type 1 for brain capillary endothelial cells map to a unique region on the viral genome. J. Virol, 70, 3401-3406.
107. MUDHASANI, R. AND FONTES, J.D. (2002). Inhibition of class II trans-activator function by HIV-1 Tat in mouse cells is independent of competition for binding to cyclin T1. Mol Immunol, 38, 539-546.
108. NATH, A., PSOOY, K., MARTIN, C., KNUDSEN, B., MAGNUSON, D.S., HAUGHEY, N. (1996). Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol, 70, 1475-80.
109. NATH, A., AND GEIGER, J. (1998). Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Progress in Neurobiology, 54, 19-33.
110. NEUVEUT, C., AND JEANG, K.T. (1996). Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol, 70, 5572-5581.
111. ORSINI, M. J., DEBOUCK, C. M., WEBB, C. L. AND LYSKO, P. G. (1996). Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons. J. Neurosi, 16, 2546-2552.
112. PARADA, C.A., AND ROEDER, R.G. (1996). Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384, 375-378.
113. PARK, I.W., WANG, J.F., AND GROOPMAN J.E. (2001a). HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood, 97: 352-358.
114. PARK, I.W., ULLRICH, C.K., SCHOENBERGER, E., GANJU, R.K., AND GROOPMAN, J.E. (2001b). HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol, 167, 2766-2771.
115. PURI, R.K., AND AGGARWAL, B.B. (1992). Human immunodeficiency virus type 1 Tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res, 52, 3787-3790.
116. PURVIS, S.F., GEORGES, D.L., WILLIAMS, T.M. AND LEDERMAN, M.M. (1992). Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell Immunol, 144, 32-42.
117. PURVIS, S.F., JACOBBERGER, J.W., SRAMKOSKI, R.M., PATKI, A.H., AND LEDERMAN, M.M. (1995). HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res Hum Retroviruses, 11, 443-450.
118. RANA, T.M., AND JEANG, K.T. (1999). Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Archives of Biochemistry and Biophysics, 365, 175-185.
119. RAPPAPORT, J., JOSEPH, J., CROUL, S., ALEXANDER, G., DEL VALLE, L., AMINI, S., AND KHALILI, K. (1999). Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukocyte Biol, 65, 458-465.
120. RE, M.C., FURLINI, G., VIGNOLI, M., RAMAZZOTTI, E., RODERIGO, G., DE ROSA, V., ZAULI, G., LOLLI, S., CAPITANI, S. AND LA PLACA, M. (1995). Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J.AIDS and Human Retrovirology, 10, 408-416.
121. RE, M.C., GIBELLINI, D., VITONE, F., AND LA PLACA, M. (2001). Antibody to HIV-1 Tat protein, a key molecule in HIV-1 pathogenesis. A brief review." Microbiologica, 24, 197-205.
122. RUSNATI, M., COLTRINI, D., CAMPIONI, D., TANGHETTI, E., CORALLINI, A, BARBANTI-BRODANO, G., GIULIANI, R., GIBELLINI, D., AND PRESTA, M. (1997). Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice. AIDS, 11, 727-736.
123. RUSNATI, M., TULIPANO, G., SPILLMANN, D., TANGHETTI, E., ORESTE, P., ZOPPETTI, G., GIACCA, M. AND PRESTA, M. (1999). Multiple interactions of HIV-1 Tat protein with size-defined heparin oligosaccharides, J. Biol. Chem, 274, 28198-28205.
124. RUSNATI, M., AND PRESTA, M. (2002). HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS associated pathology. Angiogenesis, 5, 141-151.
125. SASTRY, K.J., REDDY, H.R., PANDITA, R., TOTPAL, K., AGGARWAL, B.B. (1990). HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J Biol Chem, 265, 20091-20103.
126. SASTRY, K.J., MARIN, M.C., NEHETE, P.N., MCCONNELL, K., EL-NAGGAR, A.K., AND MCDONNELL, T.J. (1996). Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene, 13, 487-493.
127. SCALA, G., RUOCCO, M.R., AMBROSINO, C., MALLARDO, M., GIORDANO, V., BALDASSARRE, F., DRAGONETTI, E., QUINTO, I. AND VENUTA, S. (1994). The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med, 179, 961-971.
128. SECCHIERO, P., ZELLA, D., CAPITANI, S., GALLO, R.C., AND ZAULI, G. (1999). Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J Immunol, 162, 2427-2431.
129. SELLIAH, N., AND FINKEL, T.H. (2001). Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death Differ, 8, 127-136.
130. SHARMA, V., KNOBLOCH, T.J., AND BENJAMIN, D. (1995). Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem Biophys Res Commun, 208, 704-713.
131. SUBRAMANYAM, M., GUTHEIL, W.G., BACHOVCHIN, W.W. AND HUBER, B.T. (1993). Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol, 150, 2544-2553.
132. SUN, Q., MATTA, H., AND CHAUDHARY, P.M. (2005). Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat. Retrovirology, 2, 9-16.
133. TANGHETTI, E., RIA, R., DELL'ERA, P., URBINATI, C., RUSNATI, M., ENNAS, M.G., AND PRESTA, M. (2002). Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. Oncogene, 21, 3889-3897.
134. TAYLOR, J.P., POMERANTZ, R., BAGASRA O., CHOWDHURY M., RAPPAPORT J., KHALILI K., AND AMINI S. (1992a). TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J, 11, 3395-3403.
135. TAYLOR, J.P., CUPP, C., DIAZ, A., CHOWDHURY, M., KHALILI, K., AND JIMENEZ, S.A. (1992b). Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci USA, 89, 9617-9621.
136. TAYLOR, J.P., KUNDU, M., AND KHALILI, K. (1993). TAR independent activation of HIV-1 requires the activation domain but not the RNA binding domain of Tat. Virology, 195, 780-785.
137. TORNESELLO, M.L., BUONAGURO, F.M., BETH-GIRALDO, E., AND GIRALDO, G. (1993). Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology, 36, 57-64.
138. TYAGI, M., RUSNATI, M., PRESTA, M., AND GIACCA, M. (2001). Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem, 276, 3254-3261.
139. URSINI, M.V., LETTIERI, T., BRADDOCK, M., MARTINI, G. (1993). Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat. Virology, 196, 338-343.
140. VAN DE BOVENKAMP, M., NOTTET, H.S., AND PEREIRA, C.F. (2002). Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia Eur. J. Clin. Investigation, 32, 619-627.
141. VELLUTINI, C., HORSCHOWSKI, N., PHILIPPON, V., GAMBARELLI, D., NAVE, K.A., AND FILIPPI, P. (1995). Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res Hum Retroviruses, 11, 21-29.
142. VESCHAMBRE, P., ROISIN, A., AND JALINOT, P., (1997). Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. J. Gen. Virol, 78, 2235-2245.
143. VESCHAMBRE, P., SIMARD, P., AND JALINOT, P., (1995). Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol, 250, 169-180.
144. VISCIDI, R.P., MAYUR, K., LEDERMAN, H.M. AND FRANKEL, A.D. (1989). Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Sciente, 246, 1606-1608.
145. VOGEL, J., HINRICHS, S.H., REYNOLDS, R.K., LUCIW, P.A. AND JAY, G. (1988). The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature, 335, 606-611.
146. VOGEL, J., HINRICHS, S.H., NAPOLITANO, L.A., NGO, L., AND JAY, G. (1991). Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res, 51, 6686-6690.
147. VOGEL, B.E., LEE, S.J., HILDEBRAND, A., CRAIG, W., PIERSCHBACHER, M.D., WONG-STAAL, F. AND RUOSLAHTI, E. (1993) A novel integrin specificity exemplified by binding of the KvL5 integrin to the basic domain of the HIV tat protein and vitronectin. J. Cell Biol, 121, 461-468.
148. WANG, W.K., CHEN, M.Y., CHUANG, C.Y., JEANG, K.T., AND HUANG, L.M. (2000). Molecular biology of human immunodeficiency virus type 1. J Microbiol Immunol. Infect, 33, 131-140.
149. WANG, Z., MORRIS, G.F., REED, J.C., KELLY, G.D., AND MORRIS, C.B. (1999). Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology. 257, 502-510.
150. WEEKS, K.M., AND CROTHERS, D.M. (1991). RNA recognition by Tat-derived peptides: interaction in the major groove? Cell, 66, 577-588.
151. WEISSMAN, J.D., BROWN, J.A., HOWCROFT, T.K., HWANG, J., CHAWLA, A., AND ROCHE, P.A. (1998). HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc Natl Acad Sci USA, 95, 11601-11606.
152. WESTENDORP, M.O., LI, WM., FRANK, R.W., AND KRAMMER, P.H. (1994). Human immunodeficiency virus type 1 Tat up-regulates interleukin- 2 secretion in activated T cells. J. Virol, 68, 4177-4185.
153. WESTENDORP, M.O., FRANK, R., OCHSENBAUER, C., STRICKER, K., DHEIN, J., WALCZAK, H., AND KRAMMER P.H. (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature, 375, 497-500.
154. WU, Y., AND MARSH, J.W. (2003). Gene transcription in HIV infection. Microbes and Infection, 5, 1023-1027.
155. WU-BAER, F., SIGMAN, D., AND GAYNOR, R.B., (1995). Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl Acad. Sci. USA, 92, 7153-7157.
156. YANAGISHITA, M., AND HASCALL V.C. (1992). Cell surface heparan sulfate proteoglycans, J. Biol. Chem, 267, 9451-9454.
157. YANG, Y., TIKHONOV, I., RUCKWARDT, T.J., DJAVANI, M., ZAPATA, J.C., PAUZA, C.D., AND SALVATO, M.S. (2003). Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J Virol, 77, 6700-6708.
158. ZAULI, G., DAVIS, B.R., RE, M.C., VISANI, G., FURLINI, G., AND LA PLACA, M. (1992).Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood, 80, 3036-3043.
159. ZAULI, G., GIBELLINI, D., MILANI, D., MAZZONI, M., BORGATTI, P., LA PLACA, M., CAPITANI, S. (1993). Human Immunodeficiency Virus Type 1 Tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis. Cancer Res, 53, 4481-4485.
160. ZAULI, G., GIBELLINI, D., CAPUTO, A, BASSINI, A, NEGRINI, M., MONNE, M., AND CAPITANI, S. (1995). The immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T- cell lines and primary peripheral blood mononuclear cells. Blood, 86, 3823-3834.
161. ZAULI G., LA PLACA M., VIGNOLI, M., RE, M.C., GIBELLINI, D., FURLINI, G., MILANI, D., MARCHISIO, M., MAZZONI, M., AND CAPITANI, S. (1995b). An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/ proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J Acquir Immune Defic Syndr. Hum. Retrovirol, 10, 306-316.
162. ZAULI, G., PREVIATI, M., CARAMELLI, E., BASSINI, A, FALCIERI, E., GIBELLINI, D., BERTOLASO, L., BOSCO, D., ROBUFFO, I., AND CAPITANI, S. (1995c). Exogenous human immunodeficiency virus type 1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in Jurkat T cell line. Eur. J. Immunol, 25, 2695-2700.
163. ZAULI G., GIBELLINI D., CELEGHINI C., MISCHIATI C., BASSINI A, CAPITANI S., AND LA PLACA, M. (1996). Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation induction of apoptosis and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. J Immunol, 157, 2216-2224.
164. ZAULI G., AND GIBELLINI D. (1996). The human immunodeficiency virus type 1 (HIV-1) Tat protein and Bcl-2 expression. Leukemia and Lymphoma, 23, 551-560.
165. ZHANG, M., LI, X., PANG, X., DING, L., WOOD, O., CLOUSE, K.A., HEWLETT, I., DAYTON, A.I. (2002). Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J Biomed Sci, 9, 133-139.
166. ZIDOVETZKI, R., WANG, J.L., CHEN, P., JEYASEELAN, R., AND HOFMAN, F. (1998). Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain ECs via protein kinase C-and cAMP-dependent protein kinase pathways. AIDS Res Hum Retroviruses, 14, 825-833.
167. ZIEGLER, A., AND SEELIG, J. (2004). Interaction of the protein transduction domain of HIV-1 Tat with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J, 86, 254-263.